advanced search  
Updated Sep. 1, 2010
 
 
FDA UPDATE & PRODUCT NEWS
This section contains news about product launches and information on FDA approvals and clearances of drugs, devices and other products relevant to gastroenterology, endoscopy, colorectal surgery and general medicine. If you would like to feature a product in Gastroenterology & Endoscopy News’ FDA Update & Product News section, please Contact the editor.
Ethicon Endo-Surgery Now Offers Two New Staplers For Open Surgery
ISSUE: AUGUST, 2010
Ethicon Endo-Surgery has two new surgical staplers designed to optimize compression during open surgery. read more
Covidien Launches SILS Stitch Suturing Device For Laparoscopy
ISSUE: AUGUST, 2010
Covidien now offers the SILS Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. read more
FDA Clears New Addition to Covidien’s V-Loc Knotless Wound-Closure Line
ISSUE: AUGUST, 2010
The FDA has cleared the latest in Covidien’s line of absorbable wound-closure devices for knotless tissue repair, the V-Loc 90. read more
FDA Warns of Rare Cases of Liver Injury With Xenical, Alli Weight-Loss Drugs
ISSUE: AUGUST, 2010
The FDA has issued a warning about rare reports of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli. read more
FDA and NIH Launch Electronic Safety Reporting Portal
ISSUE: AUGUST, 2010
The FDA and the National Institutes of Health have launched a new Web site that, when fully developed, will provide a mechanism for reporting pre- and postmarket safety data to the federal government. read more
EndoChoice Receives FDA Clearance for Bonastent Esophageal and Biliary Stents
ISSUE: AUGUST, 2010
EndoChoice, Inc. has received 510(k) clearance from the FDA to market its Bonastent Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions and Bonastent Uncovered Biliary Stent for the treatment of malignant biliary obstructions. read more
Xifaxan 550-mg Tablets Now Available in Pharmacies
ISSUE: JULY, 2010
Following its FDA approval for the treatment of hepatic encephalopathy in March, Salix Pharmaceuticals’ rifaximin (Xifaxan) 550-mg tablets are now available in pharmacies throughout the United States. read more
Takeda Launches New Web Site To Help Patients With IBS Talk to Physicians
ISSUE: JULY, 2010
New tools are now available to help patients living with irritable bowel syndrome (IBS) describe their symptoms to a health care provider and establish a treatment plan at www.letstalkibs.com. read more

MORE
FDA UPDATE & PRODUCT NEWS
Quintron Introduces New Breath Methane Analysis In... [7/2010]
New Blood Test Differentiates Ulcerative Colitis, ... [7/2010]
FDA Warns of Fracture Risk From High-Dose, Long-te... [7/2010]
Nationwide Recall of Injectable Drugs Includes Ant... [7/2010]
FDA Forces Steris To Stop Marketing Unapproved Ste... [7/2010]
FDA Approves Third Pancreatic Enzyme Product, Panc... [6/2010]
FDA Approves New Dosing Guidance For Creon... [6/2010]
FDA Approves Combination Pain–PPI Pill for Gastrop... [6/2010]
Dexilant PPI (Formerly Kapidex) Now Available in P... [6/2010]
US Endoscopy Offers New Colon Irrigation System... [6/2010]
Olympus Offers New, Faster Endoscope Reprocessor... [6/2010]
Rotavirus Vaccines Safe for Use After Contaminatio... [6/2010]
Rifaximin Approved To Prevent Recurrence of Overt ... [5/2010]
New Device Available for Grasping Food Bolus, Fore... [4/2010]
FDA Clears HALO90 Ablation Catheter From Bârrx for... [4/2010]


FDA Update & Product News Archives

 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright © 2004 - 2010 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.